Evidence map›Paper›PMID 18714375›Full record

ArticlePloS one2008

Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation study.

Patrick Linsel-Nitschke, Anika Götz, Jeanette Erdmann, Ingrid Braenne, Peter Braund, Christian Hengstenberg, Klaus Stark, Marcus Fischer, Stefan Schreiber, Nour Eddine El Mokhtari and 26 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 83 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 10 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 10 syntheses or guidelines pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.Arteriosclerosis, thrombosis, and vascular biology · 2010 · on this map
    Trial
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Schrezenmeier, Jürgen [corrected to Schrezenmeir, Jürgen]
5 · Who and what money

Authors and funding

36 authors at 13 institutions in 4 countries.

Patrick Linsel-NitschkeMedizinische Klinik II, Universität zu Lübeck, Lübeck, Germany.
Anika Götz
Jeanette Erdmann
Ingrid Braenne
Peter Braund
Christian Hengstenberg
Klaus Stark
Marcus Fischer
Stefan Schreiber
Nour Eddine El Mokhtari
Arne Schaefer
Jürgen Schrezenmeir
Jürgen Schrezenmeier
Diana Rubin
Anke Hinney
Thomas Reinehr
Christian Roth
Jan Ortlepp
Peter Hanrath
Alistair S Hall
Massimo Mangino
Wolfgang Lieb
Claudia Lamina
Iris M Heid
Angela Doering
Christian Gieger
Annette Peters
Thomas Meitinger
H-Erich Wichmann
Inke R König
Andreas Ziegler
Florian Kronenberg
Nilesh J Samani
Heribert Schunkert
Wellcome Trust Case Control Consortium (WTCCC)
Cardiogenics Consortium
University of Lübeck · DEHelmholtz Zentrum München · DEKiel University · DEGlenfield Hospital · GBRWTH Aachen University · DEUniversity Hospital Regensburg · DEInnsbruck Medical University · ATUniversity of Duisburg-Essen · DEUniversity of Leeds · GBUniversity of Leicester · GBUniversity of Regensburg · DEUniversity of Washington · USWitten/Herdecke University · DE

Funding

British Heart FoundationMedical Research Council
6 · The paper itself

Abstract

backgroundRare mutations of the low-density lipoprotein receptor gene (LDLR) cause familial hypercholesterolemia, which increases the risk for coronary artery disease (CAD). Less is known about the implications of common genetic variation in the LDLR gene regarding the variability of cholesterol levels and risk of CAD.

methodsImputed genotype data at the LDLR locus on 1 644 individuals of a population-based sample were explored for association with LDL-C level. Replication of association with LDL-C level was sought for the most significant single nucleotide polymorphism (SNP) within the LDLR gene in three European samples comprising 6 642 adults and 533 children. Association of this SNP with CAD was examined in six case-control studies involving more than 15 000 individuals.

findingsEach copy of the minor T allele of SNP rs2228671 within LDLR (frequency 11%) was related to a decrease of LDL-C levels by 0.19 mmol/L (95% confidence interval (CI) [0.13-0.24] mmol/L, p = 1.5x10(-10)). This association with LDL-C was uniformly found in children, men, and women of all samples studied. In parallel, the T allele of rs2228671 was associated with a significantly lower risk of CAD (Odds Ratio per copy of the T allele: 0.82, 95% CI [0.76-0.89], p = 2.1x10(-7)). Adjustment for LDL-C levels by logistic regression or Mendelian Randomisation models abolished the significant association between rs2228671 with CAD completely, indicating a functional link between the genetic variant at the LDLR gene locus, change in LDL-C and risk of CAD.

conclusionA common variant at the LDLR gene locus affects LDL-C levels and, thereby, the risk for CAD.

Indexed as

Chromosomes, Human, Pair 10Genetic VariationAnticholesteremic AgentsCase-Control StudiesCholesterol, LDLChromosome MappingCoronary DiseaseHumansOligonucleotide Array Sequence AnalysisPolymorphism, Single NucleotideRandom AllocationReceptors, LDLRisk AssessmentRisk FactorsAnticholesteremic AgentsCholesterol, LDLReceptors, LDL

Identifiers

PMID18714375
PMCPMC2500189
OpenAlexW1970049038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.